Literature DB >> 15017599

Acute vascular humoral rejection in a sensitized cardiac graft recipient: diagnostic value of C4d immunofluorescence.

Jean-Paul Duong Van Huyen1, Paul Fornes, Romain Guillemain, Catherine Amrein, Patrick Chevalier, Christian Latremouille, Caroline Creput, Denis Glotz, Dominique Nochy, Patrick Bruneval.   

Abstract

A 37-year-old female patient had a cardiac transplantation for dilated cardiomyopathy. She was sensitized by two pregnancies showing anti-human leukocyte antigen I and II antibodies. The pretransplantation crossmatch was negative, but she developed acute humoral rejection characterized by vascular C4d deposits, arteriolitis, and intravascular leukocyte accumulation and adhesion in venules. Although C4d deposits disappeared in 4 weeks, she had persistent endothelial cell activation (endothelial expression of ELAM-1, VCAM-1, or human leukocyte antigen class II) throughout the 6 months of follow-up. Although she received intensive immunosuppression, she presented three episodes of acute cellular rejection during that period of time. This case shows that C4d deposits represent a sensitive marker of acute humoral rejection in cardiac transplantation. Therefore, C4d immunofluorescence should be more frequently assessed in endomyocardial biopsies.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15017599     DOI: 10.1016/j.humpath.2003.10.016

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  3 in total

Review 1.  An approach to endomyocardial biopsy interpretation.

Authors:  K S Cunningham; J P Veinot; J Butany
Journal:  J Clin Pathol       Date:  2006-02       Impact factor: 3.411

2.  Antibody-mediated rejection in human cardiac allografts: evaluation of immunoglobulins and complement activation products C4d and C3d as markers.

Authors:  E R Rodriguez; Diane V Skojec; Carmela D Tan; Andrea A Zachary; Edward K Kasper; John V Conte; William M Baldwin
Journal:  Am J Transplant       Date:  2005-11       Impact factor: 8.086

3.  Detection of anti-HLA antibodies in maternal blood in the second trimester to identify patients at risk of antibody-mediated maternal anti-fetal rejection and spontaneous preterm delivery.

Authors:  JoonHo Lee; Roberto Romero; Yi Xu; Jezid Miranda; Wonsuk Yoo; Piya Chaemsaithong; Juan Pedro Kusanovic; Tinnakorn Chaiworapongsa; Adi L Tarca; Steven J Korzeniewski; Sonia S Hassan; Nandor Gabor Than; Bo Hyun Yoon; Chong Jai Kim
Journal:  Am J Reprod Immunol       Date:  2013-08       Impact factor: 3.886

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.